Cargando…

Candidate Gene in Predicting In Vivo Ovarian Cancer Response to Combination Therapy with Paraplatin and Paclitaxel

Detalles Bibliográficos
Autores principales:	Mirhashemi, Ramin, Arena, J. Fernando, Frudakis, Tony, Lambrou, Nicholas, Arboleda, Jane, Hunt, Marsha, Medranda, Maria, Averette, Hervy, Penalver, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	TheScientificWorldJOURNAL 2002
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009371/ https://www.ncbi.nlm.nih.gov/pubmed/29973784 http://dx.doi.org/10.1100/tsw.2002.10

Ejemplares similares

Case report: Remarkable response to a novel combination of mitotane, etoposide, paraplatin, and sintilimab in a patient with metastatic adrenocortical carcinoma
por: Weng, Yan, et al.
Publicado: (2023)

Phase II study of intraperitoneal submicron particle paclitaxel (SPP) plus IV carboplatin and paclitaxel in patients with epithelial ovarian cancersurgery
por: Mullany, Sally, et al.
Publicado: (2020)

Paclitaxel and cisplatin chemotherapy for ovarian cancer during pregnancy: case report and review of the literature
por: Serkies, Krystyna, et al.
Publicado: (2011)

CHFR and Paclitaxel Sensitivity of Ovarian Cancer
por: Wahner Hendrickson, Andrea E., et al.
Publicado: (2021)

Effect of Ethanol in Paclitaxel Injections on the Ethanol Concentration in Exhaled Breath
por: Aomori, Tohru, et al.
Publicado: (2012)

Comparative effectiveness and durability of COVID‐19 vaccination against death and severe disease in an ongoing nationwide mass vaccination campaign
por: Lytras, Theodore, et al.
Publicado: (2022)

Clinical trials and progress with paclitaxel in ovarian cancer
por: Kumar, Sanjeev, et al.
Publicado: (2010)

Cardioprotective effect of royal jelly on paclitaxel-induced cardio-toxicity in rats
por: Malekinejad, Hassan, et al.
Publicado: (2016)

Effects of Goshajinkigan, Hachimijiogan, and Rokumigan on Mechanical Allodynia Induced by Paclitaxel in Mice
por: Andoh, Tsugunobu, et al.
Publicado: (2014)

Analysis of protein-protein interaction network based on transcriptome profiling of ovine granulosa cells identifies candidate genes in cyclic recruitment of ovarian follicles
por: Talebi, Reza, et al.
Publicado: (2018)

Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer
por: Kavanagh, John J, et al.
Publicado: (2010)

Fatal outcome of a hypersensitivity reaction to paclitaxel: a critical review of premedication regimens
por: Kloover, J S, et al.
Publicado: (2004)

Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer
por: Kampan, Nirmala Chandralega, et al.
Publicado: (2015)

Effects of paclitaxel and cisplatin on in vitro ovarian follicle development
por: Kim, Yoon Young, et al.
Publicado: (2019)

Onvansertib and paclitaxel combined in platinum-resistant ovarian carcinomas
por: Affatato, Roberta, et al.
Publicado: (2022)

Short-term adoption rates for a web-based portal within the intranet of a hospital information system
por: Kotoulas, Athanasios, et al.
Publicado: (2019)

Comparison of paclitaxel liposomes combined with carboplatin versus paclitaxel combined with carboplatin in the treatment of advanced ovarian cancer
por: Tan, Xiangbin, et al.
Publicado: (2023)

Mutations in the PCNA-binding site of CDKN1C inhibit cell proliferation by impairing the entry into S phase
por: Borges, Kleiton S, et al.
Publicado: (2015)

Dynamical decoration of stabilized-microtubules by Tau-proteins
por: Hervy, Jordan, et al.
Publicado: (2019)

Comparative study of adsorptive role of carbonaceous materials in removal of UV-active impurities of paclitaxel extracts()
por: Nasiri, Jaber, et al.
Publicado: (2015)

Berberine Alleviates Paclitaxel-Induced Neuropathy
por: Rezaee, Ramin, et al.
Publicado: (2019)

Adipose-Derived Stem Cells Primed with Paclitaxel Inhibit Ovarian Cancer Spheroid Growth and Overcome Paclitaxel Resistance
por: Borghese, Cinzia, et al.
Publicado: (2020)

Rationale for combination of paclitaxel and CDK4/6 inhibitor in ovarian cancer therapy — non-mitotic mechanisms of paclitaxel
por: Smith, Elizabeth R., et al.
Publicado: (2022)

Phase I study of cisplatin analogue nedaplatin (254-S) and paclitaxel in patients with unresectable squamous cell carcinoma
por: Sekine, I, et al.
Publicado: (2004)

Jetstream Atherectomy with Paclitaxel-Coated Balloons: Two-Year Outcome of the Prospective Randomized JET-RANGER Study
por: Shammas, Nicolas W, et al.
Publicado: (2023)

Characterisation of five candidate genes within the ETEC F4ab/ac candidate region in pigs
por: Jacobsen, Mette, et al.
Publicado: (2011)

TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
por: Wang, Ning, et al.
Publicado: (2012)

Coronary Artery Thrombosis Associated With Paclitaxel in Advanced Ovarian Cancer
por: Park, Sang-Ho, et al.
Publicado: (2009)

Evaluation of the efficacy of paclitaxel with curcumin combination in ovarian cancer cells
por: Liu, Zeng, et al.
Publicado: (2016)

Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells
por: Miyamoto, Mayuko, et al.
Publicado: (2020)

Asparagus officinalis combined with paclitaxel exhibited synergistic anti-tumor activity in paclitaxel-sensitive and -resistant ovarian cancer cells
por: Zhang, Xin, et al.
Publicado: (2022)

CYP1B1 enhances the resistance of epithelial ovarian cancer cells to paclitaxel in vivo and in vitro
por: ZHU, ZHUANGYAN, et al.
Publicado: (2015)

In vivo detection of dysregulated choline metabolism in paclitaxel-resistant ovarian cancers with proton magnetic resonance spectroscopy
por: Lu, Jing, et al.
Publicado: (2022)

A 20 Years Retrospective Descriptive Study of Human Cystic Echinococcosis and the Role of Albendazole Concurrent with Surgical Treatment: 2001–2021
por: Mahmoodi, Setareh, et al.
Publicado: (2023)

A new superinvasive in vitro phenotype induced by selection of human breast carcinoma cells with the chemotherapeutic drugs paclitaxel and doxorubicin
por: Glynn, S A, et al.
Publicado: (2004)

Looking through the cracks of diabetic candidal balanoposthitis!
por: Verma, Shyam B, et al.
Publicado: (2011)

First-line treatment for advanced ovarian cancer: paclitaxel, platinum and the evidence
por: Sandercock, J, et al.
Publicado: (2002)

Effects of suberoylanilide hydroxamic acid (SAHA) combined with paclitaxel (PTX) on paclitaxel-resistant ovarian cancer cells and insights into the underlying mechanisms
por: Liu, Zhaohui, et al.
Publicado: (2014)

Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer
por: Huang, Chen-Yu, et al.
Publicado: (2020)

CRM197 reverses paclitaxel resistance by inhibiting the NAC‐1/Gadd45 pathway in paclitaxel‐resistant ovarian cancer cells
por: Tang, Xiao‐han, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_v91drsvopuakq1b0sm5ku4lmi7